143 results match your criteria: "University Hospital St-Luc[Affiliation]"

Background And Purpose: Various electrodiagnostic criteria have been developed in Guillain-Barré syndrome (GBS). Their performance in a broad representation of GBS patients has not been evaluated. Motor conduction data from the International GBS Outcome Study (IGOS) cohort were used to compare two widely used criterion sets and relate these to diagnostic amyotrophic lateral sclerosis criteria.

View Article and Find Full Text PDF

Leigh syndrome spectrum (LSS) is a primary mitochondrial disorder defined neuropathologically by a subacute necrotizing encephalomyelopathy and characterized by bilateral basal ganglia and/or brainstem lesions. LSS is associated with variants in several mitochondrial DNA genes and more than 100 nuclear genes, most often related to mitochondrial complex I (CI) dysfunction. Rarely, LSS has been reported in association with primary Leber hereditary optic neuropathy (LHON) variants of the mitochondrial DNA, coding for CI subunits (m.

View Article and Find Full Text PDF

RECIST 1.1 criteria are commonly used with computed tomography (CT) to evaluate the efficacy of systemic treatments in patients with neuroendocrine tumors (NETs) and liver metastases (LMs), but their relevance is questioned in this setting. We aimed to explore alternative criteria using different numbers of measured LMs and thresholds of size and density variation.

View Article and Find Full Text PDF
Article Synopsis
  • Homograft heart valves are often better for fixing heart problems in young women, athletes, and patients with active infections.
  • There is a shortage of donated tissues for these valves, so a new program is being started to help collect more tissue donations.
  • Between 2020 and 2022, doctors at the hospital collected several heart and lung parts for transplant, but some were discarded due to issues like contamination or damage.
View Article and Find Full Text PDF

Background: Vertical Paramedian Hemispherotomy (VPH) is considered an effective surgical treatment for drug-resistant epilepsy with 80% of patients experiencing seizure freedom or worthwhile improvement. Identifying persistent connective tracts is challenging in failed VPH.

Methods: We reviewed our series of consecutive patients undergoing VPH for hemispheric drug-resistant epilepsy and included cases with recurrent epileptic seizures undergoing second surgery with at least 6 months of postoperative follow-up.

View Article and Find Full Text PDF

An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort.

Neurology

September 2022

From the Departments of Neurology (S.E.L., S. Arends, B.v.d.B., A.Y.D., P.A.v.D., K.K., L.W.G.L., W.V.R., J.R., C.V., B.C.J.), and Viroscience (A.A.v.d.E.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Department of Neurology (H.A., T.H.), Aarhus University Hospital, Denmark; Department of Neurology (G.A.), Mental Health and Sensory Organs (NESMOS), Faculty of Medicine and Psychology, University of Rome "Sapienza," Sant' Andrea Hospital, Italy; Department of Neurology (S. Arends), Haga Teaching Hospital, The Hague, the Netherlands; Department of Neurology (S. Attarian), Reference Centre for NMD, CHU Timone, Marseille, France; Department of Neurology (F.A.B.), Instituto de Investigaciones Neurológicas Raúl Carrea, FLENI, Buenos Aires, Argentina; Division of Neurology (K.J.B., E.L.P.), Department of Medicine, Groote Schuur Hospital, University of Cape Town, South Africa; Department RH-MDC-Immunology (M.R.B., M.M.), Reinier de Graaf Gasthuis, Delft, the Netherlands; Department of Neurology (L.B.), IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Neurology (B.v.d.B., F.H.V.), Franciscus Gasthuis & Vlietland, Schiedam, the Netherlands; Department of Neurology (P.V.d.B.), University Hospital St. Luc, University of Louvain, Brussels, Belgium; Department of Neurology (J.B.), Saarland University Medical School, Homburg (previous hospital), and MVZ Pfalzklinikum (J.B.), Kusel, Germany (current hospital); Department of Neurology (M.B.), Leeds Teaching Hospitals, United Kingdom; Department of Neurology (C.C., V.N.-H.), Neuromuscular Unit, Bellvitge University Hospital-IDIBELL, CIBERER, Barcelona, Spain; Department of Neurology (D.R.C.), Johns Hopkins University, Baltimore, MD; Institute of Infection, Immunity and Inflammation (A.D., H.J.W.), University of Glasgow, United Kingdom; National Hospital Copenhagen (C.D.d.l.C.), Copenhagen, Denmark; Department of Clinical Neurosciences (T.E.F.), University of Calgary, Alberta, Canada; Nuffield Department of Clinical Neurosciences (J.F., S.R.), University of Oxford, John Radcliffe Hospital, United Kingdom; Department of Neurology (T.G.-S., J.P.), Hospital Clínico de Santiago, Spain; Neurology, Neuromuscular Diseases, Electromyography (J.M.G.), Hospital for Special Surgery; Weill Medical College of Cornell University (J.M.G.), New York; Department of Neurology (K.C.G., B.S.), Tufts University School of Medicine, Boston, MA; Department of Neurology (V.G.), Montefiore Medical Center, New York; Department of Neurology (R.D.M.H.), King's College Hospital, London, United Kingdom; Department of Neurology (H.-P.H.), University of Düsseldorf, Germany; Brain and Mind Centre (H.-P.H.), University of Sydney, Australia; Department of Neurology (H.-P.H.), Medical University of Vienna, Austria; Laboratory of Gut-Brain Signaling (I.H., I.J., Z.I., Q.D.M.), Laboratory Sciences and Services Division, icddr,b, Dhaka, Bangladesh; Department of Neurology (J.V.H., S.H.S.), Odense University Hospital, Denmark; Department of Neurology (J.K.L.H.), The Walton Centre, Liverpool, United Kingdom; Department of Neurology (S. Karafiath), Utah Valley University, Orem; Department of Neurology (H.D.K.), University Health Network, University of Toronto, ON, Canada; Department of Neurology (R.P.K., K.K.), Albert Schweitzer Hospital, Dordrecht, the Netherlands; Department of Neurology (N.K.), University of Vermont Medical Centre, Burlington; Department of Neurology (M.K., S. Kusunoki), Kindai University, Faculty of Medicine, Osaka, Japan; Department of Neurology (L.W.G.L., L.H.V.), St. Elisabeth-TweeSteden Hospital, Tilburg, the Netherlands; Department of Neurology (S. Kuwabara), Chiba University, Japan; Department of Neurology (H.C.L.), University Hospital of Cologne, Germany; Department of Neurology (L.M.-A., L.Q.), Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Spain; Department of Neurology (J.A.L.M.), Royal Victoria Infirmary, Newcastle upon Tyne Hospitals NHS Foundation Trust, United Kingdom; Department of Neurology (S.M.), Hospital de Pediatría J.P. Garrahan, Buenos Aires, Argentina; Neuromuscular and Neuroimmunology Service (E.N.-O.), IRCCS Humanitas Research Hospital, Milan University, Italy; Department of Clinical Neurophysiology (Y.P.), Reference Centre for NMD, CHU Nantes, France; Department of Neurology (R.R.), Hospital Británico, Buenos Aires, Argentina; Department of Immunology (W.V.R., A.P.T.-G., R.H., B.C.J.), Erasmus MC University Medical Center, Rotterdam, the Netherlands; Department of Neurology (S.R.), Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital; Department of Neurology (R.C.R.), Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge Biomedical Campus, United Kingdom; Department of Medicine (N.S., T.C.-Y.), University of Malaya, Kuala Lumpur; Department of Neurology (S.H.S.), University of Southern Denmark, Odense; Department of Clinical Neurophysiology (H.T.), Aarhus University Hospital, Denmark; and Hospital Universitario Marques de Valdecilla (M.J.S.T.), Santander, Cantabria, Spain.

Background And Objectives: Infections play a key role in the development of Guillain-Barré syndrome (GBS) and have been associated with specific clinical features and disease severity. The clinical variation of GBS across geographical regions has been suggested to be related to differences in the distribution of preceding infections, but this has not been studied on a large scale.

Methods: We analyzed the first 1,000 patients included in the International GBS Outcome Study with available biosamples (n = 768) for the presence of a recent infection with , hepatitis E virus, , cytomegalovirus, and Epstein-Barr virus.

View Article and Find Full Text PDF

Background: Intestinal T cells are key in gut barrier function. Their role in early stages of alcohol-associated liver disease (ALD) remain unknown.

Aim: To explore the links between intestinal T cells, microbial translocation and ALD METHODS: Patients with alcohol use disorder (AUD) following a rehabilitation programme were compared to subjects with non-alcoholic fatty liver disease (NAFLD) and healthy controls.

View Article and Find Full Text PDF
Article Synopsis
  • Researchers wanted to find out how to tell if a redo liver transplant (redo-LT) is successful or not, especially since there aren't many organs available to transplant.
  • They looked at data from 22 hospitals from 2010 to 2018, focusing on certain patients who had a better chance of having a good outcome after the surgery.
  • They found that while most patients had a high survival rate after 1 year, those who had redo-LT for specific complications did not do as well, showing that some cases are riskier than others.
View Article and Find Full Text PDF

Background: The efficacy of the subthalamic nucleus (STN) stimulation for Parkinson's disease has been widely established. The microlesion effect (MLE) due to deep brain stimulation (DBS) electrode implantation has been reputed to be a good predictor for long-term efficacy of the procedure but its analysis in asleep implantation is still unclear. We thus analyzed MLE rate in our strategy of targeting the STN on MRI under general anesthesia and its correlation with our long-term results.

View Article and Find Full Text PDF

Electrodiagnostic (EDx) studies are helpful in diagnosing and subtyping of Guillain-Barré syndrome (GBS). Published criteria for differentiation into GBS subtypes focus on cutoff values, but other items receive less attention, although they may influence EDx subtyping: (a) extensiveness of EDx testing, (b) nerve-specific considerations, (c) distal compound muscle action potential (CMAP)-amplitude requirements, (d) criteria for conduction block and temporal dispersion. The aims of this study were to investigate how these aspects were approached by neuromuscular EDx experts in practice and how this was done in previously published EDx criteria for GBS.

View Article and Find Full Text PDF

European Academy of Neurology guidance for developing and reporting clinical practice guidelines on rare neurological diseases.

Eur J Neurol

June 2022

SC Neurology, Department of Emergency and Critical Care, Fondazione IRCCS 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Italy.

Background And Purpose: Rare diseases affect up to 29 million people in the European Union, and almost 50% of them affect the nervous system or muscles. Delays in diagnosis and treatment onset and insufficient treatment choices are common. Clinical practice guidelines (CPGs) may improve the diagnosis and treatment of patients and optimize care pathways, delivering the best scientific evidence to all clinicians treating these patients.

View Article and Find Full Text PDF

Objective: To describe the heterogeneity of electrodiagnostic (EDx) studies in Guillain-Barré syndrome (GBS) patients collected as part of the International GBS Outcome Study (IGOS).

Methods: Prospectively collected clinical and EDx data were available in 957 IGOS patients from 115 centers. Only the first EDx study was included in the current analysis.

View Article and Find Full Text PDF

Optimizing patient safety and quality improvement is increasingly important in surgery. Benchmarks and clinical quality registries are being developed to assess the best achievable results for several surgical procedures and reduce unwarranted variation between different centers. However, there is no clinical database from international centers for establishing standardized reference values of patients undergoing surgery for mesial temporal lobe epilepsy.

View Article and Find Full Text PDF

ECHDC1 knockout mice accumulate ethyl-branched lipids and excrete abnormal intermediates of branched-chain fatty acid metabolism.

J Biol Chem

October 2021

Department of Biochemistry, de Duve Institute, UCLouvain, Brussels, Belgium; Walloon Excellence in Lifesciences and Biotechnology (WELBIO), Brussels, Belgium. Electronic address:

The cytosolic enzyme ethylmalonyl-CoA decarboxylase (ECHDC1) decarboxylates ethyl- or methyl-malonyl-CoA, two side products of acetyl-CoA carboxylase. These CoA derivatives can be used to synthesize a subset of branched-chain fatty acids (FAs). We previously found that ECHDC1 limits the synthesis of these abnormal FAs in cell lines, but its effects in vivo are unknown.

View Article and Find Full Text PDF

Objectives: Fluoropyrimidines such as 5-Fluorouracil (5-FU), capecitabine and tegafur are drugs that are often used in the treatment of maliginancies. The enzyme dihydropyrimidine dehydrogenase (DPD) is the first and rate limiting enzyme of 5-FU catabolism. Genetic variations within the DPYD gene (encoding for DPD protein) can lead to reduced or absent DPD activity.

View Article and Find Full Text PDF

Purpose: Radiation-induced cancers due to imaging devices concern above all the growing child, however, to date, intraoperative irradiation doses are not well-documented in children. The goal of the study was to evaluate the intraoperative doses received by patients operated with the use of a C-arm in traumatology, as well as the lifetime attributable risk of cancer death (LAR) related to the irradiation of the imaging device.

Methods: From 1 April 2017 to 31 March 2019, we started a multicentre study and prospectively recruited all consecutive children who needed elastic stable intramedullary nailing (ESIN) for long-bone fracture.

View Article and Find Full Text PDF

Introduction: The descending genicular artery (DGA) has recently been mentioned as accompanying some nerves in the medial aspect of the knee joint. This could be clinically relevant as the arteries could serve as landmarks for accurate nerve capture during ultrasound-guided nerve blockade or ablation. The aim of this cadaveric study was to investigate the anatomical distribution of the DGA, assess the nerves running alongside its branches, and discuss the implications for regional anesthesia and knee pain interventions.

View Article and Find Full Text PDF

Background: Spinal cord stimulation (SCS) is a neuromodulation process to treat neuropathic pain, initially developed on tonic paresthesia-based stimulation. In the last decade, 3 major paresthesia-free SCSs have emerged. Several studies show their superiority over tonic stimulation.

View Article and Find Full Text PDF

Background: Progressive autograft dilation and need for later reoperation remain major concerns of the Ross procedure. The study investigates the clinical outcome after the Ross operation, including a longitudinal analysis of autograft dimensions over 25 years.

Methods: From November 1991 to April 2019, 137 patients underwent a Ross procedure at the University Hospitals of UCL (Université catholique de Louvain)-Brussels and Ghent.

View Article and Find Full Text PDF

This manuscript represents a collaboration from an international group of quality and safety expert radiation oncologists. It is a position/review paper with the specific aim of defining the role of the radiation oncologist in quality and safety management. This manuscript is unique in that we recommend specific quality assurance/control tasks and correlated quality and indicators and safety measures that are the responsibility of the radiation oncologist.

View Article and Find Full Text PDF

Postoperative Infections Associated With Prolonged Spinal Cord Stimulation Trial Duration (PROMISE RCT).

Neuromodulation

July 2020

Department of Neurosurgery, Poitiers University Hospital, Poitiers, France, PRISMATICS Lab, Faculty of Medicine, University of Poitiers, Poitiers, France.

Article Synopsis
  • The PROMISE study investigated spinal cord stimulation (SCS) for low back pain, revealing a higher infection rate in Belgium compared to other countries, which led to a review of infections post-study.
  • Among the 174 participants, 9 infections (5.2%) were documented, and a significant correlation was found between longer trial duration and infection rates, with a marked increase in risk for trials over 10 days.
  • The findings suggest that limiting SCS trial duration to 10 days may reduce the risk of infection, supporting a cause-effect relationship between prolonged trials and infections.
View Article and Find Full Text PDF

Context: Signs and symptoms of Cushing's syndrome (CS) overlap with common diseases, such as the metabolic syndrome, obesity, osteoporosis, and depression. Therefore, it can take years to finally diagnose CS, although early diagnosis is important for prevention of complications.

Objective: The aim of this study was to assess the time span between first symptoms and diagnosis of CS in different populations to identify factors associated with an early diagnosis.

View Article and Find Full Text PDF

Current treatment practice of Guillain-Barré syndrome.

Neurology

July 2019

From the Departments of Neurology (C.V., A.Y.D., B.C.J.) and Immunology (B.C.J.), Erasmus MC, University Medical Center Rotterdam, the Netherlands; Department of Neurology (G.G.), University Hospital of Modena, Italy; Department of Neurology (A.D., H.J.W.), University of Glasgow, UK; Department of Neurology (W.W.), University of Vermont Medical Center, Burlington; Department of Clinical Neurophysiology (Y.P.), Reference Centre for NMD, Nantes University Hospital, France; Department of Medicine (N.S.), University of Malaya, Kuala Lumpur, Malaysia; Department of Neurology (S.K.), Kindai University Faculty of Medicine, Osaka, Japan; Department of Neurology (H.C.L.), Universitätsklinikum Köln, Germany; Department of Neurology (T.H.), Aarhus University Hospital, Denmark; Department of Neurology (S.M.), Hospital de Pediatría J.P. Garrahan, Buenos Aires, Argentina; Department of Neurology (P.V.d.B.), University Hospital St-Luc, University of Louvain, Brussels, Belgium; and Department of Neurology (D.R.C.), Johns Hopkins University School of Medicine, Baltimore, MD.

Objective: To define the current treatment practice of Guillain-Barré syndrome (GBS).

Methods: The study was based on prospective observational data from the first 1,300 patients included in the International GBS Outcome Study. We described the treatment practice of GBS in general, and for (1) severe forms (unable to walk independently), (2) no recovery after initial treatment, (3) treatment-related fluctuations, (4) mild forms (able to walk independently), and (5) variant forms including Miller Fisher syndrome, taking patient characteristics and hospital type into account.

View Article and Find Full Text PDF